Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
7,420.00    35.00 (0.47%)
Bid:
7,425.00
Ask:
7,430.00
Spread: 5.00 (0.067%)
Market Cap: £32.85b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

SID Appointment and Board Committee Changes

10 Apr 2026 11:00

RNS Number : 0137A
Coca-Cola Europacific Partners plc
10 April 2026
 

SENIOR INDEPENDENT DIRECTOR APPOINTMENT AND

CHANGES IN COMPOSITION OF THE BOARD COMMITTEES

 

The Board of Directors of Coca-Cola Europacific Partners plc (CCEP) announces the following changes to the composition of the Board Committees with effect from the conclusion of the Annual General Meeting (AGM) to be held on 28 May 2026:

 

· Mary Harris, Independent Non-executive Director, will be appointed Senior Independent Director;

 

· Nathalie Gaveau, Independent Non-executive Director, will retire as a member of the Environmental, Social and Governance Committee;

 

· Dessi Temperley, Independent Non-executive Director, will be appointed as a member of the Environmental, Social and Governance Committee;

 

· Nicolas Mirzayantz, Independent Non-executive Director, will be appointed as a member of the Nomination Committee and will retire as a member of the Audit Committee;

 

· Mark Price, Independent Non-executive Director, will be appointed as Chairman of the Affiliated Transaction Committee; and

 

· subject to their formal appointment as Independent Non-executive Directors at the AGM:

 

Laurence Debroux and Uvashni Raman will be appointed as members of the Audit Committee;

Laurence Debroux will be appointed as a member of the Remuneration Committee; and

Uvashni Raman will be appointed as a member of the Affiliated Transaction Committee.

 

Following the changes noted above, the membership of the Committees will be as follows:

 

Audit Committee

Affiliated Transaction Committee

Environmental, Social and Governance Committee

Dessi Temperley (Chairman)

Mark Price (Chairman)

Mario Rotllant (Chairman)

Robert Appleby

Sol Daurella

Robert Appleby

John Bryant

Nathalie Gaveau

Nicolas Mirzayantz

Laurence Debroux

Alfonso Líbano Daurella

Dessi Temperley

Uvashni Raman

Uvashni Raman

Nancy Quan

   

Nomination Committee

Remuneration Committee

Mary Harris (Chairman)

John Bryant (Chairman)

Manolo Arroyo

Manolo Arroyo

Sol Daurella

José Ignacio Comenge

Nicolas Mirzayantz

Laurence Debroux

Mark Price

Mary Harris

 

This notification is made in accordance with UK Listing Rule 6.4.6R(3).

 

CONTACTS

 

Company Secretariat

Svetlana Walker

svetlana.walker@ccep.com

Investor Relations

Sarah Willett

sarah.willett@ccep.com

Media Relations

Shanna Wendt

mediaenquiries@ccep.com

 

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock Exchange and on the Spanish Stock Exchanges, and a constituent of both the NASDAQ 100 and FTSE 100 indices, trading under the symbol CCEP (ISIN No. GB00BDCPN049).

For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANLEFENKEEA
Date   Source Headline
23rd Mar 20221:50 pmRNSDirector/PDMR Shareholding
18th Mar 20222:15 pmRNSBlock listing Interim Review
17th Mar 20225:30 pmRNSDirector/PDMR Shareholding
15th Mar 20226:11 pmRNSAnnual Financial Report
14th Mar 20226:30 pmRNSDirector/PDMR Shareholding
10th Mar 20226:00 pmRNSDirector/PDMR Shareholding
9th Mar 20229:06 amRNSDirector/PDMR Shareholding
8th Mar 20224:00 pmRNSDirector/PDMR Shareholding
4th Mar 20224:00 pmRNSDirector/PDMR Shareholding
1st Mar 20222:00 pmRNSTotal Voting Rights
28th Feb 20225:30 pmRNSDirector/PDMR Shareholding
23rd Feb 20225:30 pmRNSDirector/PDMR Shareholding
16th Feb 20224:35 pmRNSPrice Monitoring Extension
16th Feb 20227:00 amRNSPreliminary Unaudited Results Q4 & FY 2021
1st Feb 20221:30 pmRNSTotal Voting Rights
24th Jan 20223:00 pmRNSDirector/PDMR Shareholding
4th Jan 202212:45 pmRNSTotal Voting Rights
21st Dec 20213:45 pmRNSDirector/PDMR Shareholding
16th Dec 20211:45 pmRNSDirector/PDMR Shareholding
1st Dec 20212:45 pmRNSTotal Voting Rights
23rd Nov 20213:15 pmRNSDirector/PDMR Shareholding
17th Nov 20214:35 pmRNSPrice Monitoring Extension
9th Nov 20217:00 amRNSQ3 Trading Update & FY21 Dividend Declaration
1st Nov 20212:30 pmRNSTotal Voting Rights
25th Oct 20214:41 pmRNSSecond Price Monitoring Extn
25th Oct 20214:36 pmRNSPrice Monitoring Extension
21st Oct 20214:41 pmRNSSecond Price Monitoring Extn
21st Oct 20214:36 pmRNSPrice Monitoring Extension
20th Oct 20214:40 pmRNSSecond Price Monitoring Extn
20th Oct 20214:35 pmRNSPrice Monitoring Extension
20th Oct 20214:30 pmRNSDirector/PDMR Shareholding
15th Oct 20214:41 pmRNSSecond Price Monitoring Extn
15th Oct 20214:36 pmRNSPrice Monitoring Extension
14th Oct 20214:41 pmRNSSecond Price Monitoring Extn
14th Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20212:00 pmRNSTotal Voting Rights
30th Sep 20212:00 pmRNSDirector/PDMR Shareholding
17th Sep 202112:30 pmRNSBlock listing Interim Review
9th Sep 20215:00 pmRNSDirector/PDMR Shareholding
7th Sep 20211:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSResults for the six months ended 2 July 2021
1st Sep 20211:00 pmRNSTotal Voting Rights
20th Aug 20219:30 amRNSDirector/PDMR Shareholding
2nd Aug 20211:30 pmRNSTotal Voting Rights
28th Jul 20214:35 pmRNSPrice Monitoring Extension
20th Jul 202111:30 amRNSDirector/PDMR Shareholding
2nd Jul 20212:00 pmRNSDirector/PDMR Shareholding
1st Jul 20214:30 pmRNSTotal Voting Rights
23rd Jun 20213:00 pmRNSDirector/PDMR Shareholding
11th Jun 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.